Australia markets closed

Helius Medical Technologies, Inc. (HSDT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.07+0.04 (+0.89%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.03
Open5.10
Bid0.00 x 0
Ask0.00 x 0
Day's range4.90 - 5.10
52-week range4.29 - 14.45
Volume8,364
Avg. volume411,754
Market cap4.503M
Beta (5Y monthly)1.55
PE ratio (TTM)N/A
EPS (TTM)-14.56
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.47
  • GlobeNewswire

    Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

    -- Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) ---- Over 28,000 cases of multiple sclerosis (MS) are reported to the VA annually -- NEWTOWN, Pa., April 03, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced it has partnered with Lovell Government S

  • Insider Monkey

    Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call Transcript

    Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call Transcript March 28, 2024 Helius Medical Technologies, Inc. beats earnings expectations. Reported EPS is $-1.47, expectations were $-4.05. HSDT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]

  • GlobeNewswire

    Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

    -- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December 31, 2023. Fourth Quarter and Recent Business Updates Secured Healthcare Common Procedure Coding System (“HCPCS”) Level II codes for the Portable